Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00572234 · ClinicalTrials.gov registry record · NA
Bupropion in the Treatment of Methamphetamine Dependence
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00572234 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 40 participants.
The verdict
NCT00572234, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Methamphetamine dependence is a significant drug use disorder in the Midwest. While a number of psychosocial and pharmacological treatments have been studied, no specific treatments for methamphetamine have been identified. This study is a collaborative pre-clinical and clinical partnership examining bupropion in the treatment of methamphetamine dependence.
Interventions
- DRUG bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-08-31 |
| Est. Completion | 2011-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00572234
The ClinicalTrials.gov registry entry for NCT00572234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which bupropion SR is the first listed.
NCT00572234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00572234 about?
NCT00572234 is a clinical study titled "Bupropion in the Treatment of Methamphetamine Dependence". Methamphetamine dependence is a significant drug use disorder in the Midwest. While a number of psychosocial and pharmacological treatments have been studied, no specific treatments for methamphetamine have been identified. This study is a collaborative pre-clinical and clinical partnership examinin...
What is the current status of trial NCT00572234?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-08-31. Estimated completion is 2011-05-20.
What interventions are being tested in trial NCT00572234?
The interventions under investigation include: bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00572234?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.